With all the interesting new research coming out, it’s good that we have bloggers to help us stay on top of it all. The Olive Ridley Crawl explains the basics behind the reports on chemicals linked to breast cancer; Corpus Callosum looks at a Health Affairs article that helps put drug risks in perspective; Andrew Leonard at How the World Works highlights a paper on undocumented migrant berry pickers in the Pacific Northwest and Oaxaca; Kate Shepard at Gristmill summarizes new thinking on the long-cherished “the dose makes the poison” idea; and Dave Munger at Cognitive Daily describes a study that attempts to separate health from social influences on brain development.
Meanwhile, Revere at Effect Measure and Angry Toxicologist report that Coca-Cola has promised to get the benzene out of its products. (Two ingredients – ascorbic acid and either sodium benzoate or potassium benzoate – that are found in several popular beverages can mix and form benzene; Environmental Working Group has been pressuring companies to reformulate beverages that contain these ingredients.)
Elsewhere in the blogosphere …
Four U.S. members of Congress are living on food stamps for a week to draw attention to the hunger and poor nutrition that millions of families face. Congressman Jim McGovern, with his wife Lisa McGovern, and Congressman Tim Ryan are blogging about the experience (hat tip to DCist).
Jessica Gottlieb at Global Health Policy reports that some African countries are considering “paying for performance” in health.
Ross Gelbspan at DeSmogBlog alerts us that ExxonMobil hasn’t kept up with its promise to stop funding think tanks that try to cast doubt on global warming.
Gavin at RealClimate checks back in on the climate change projections that Jim Hansen made back in 1988.
Matt Madia at Reg Watch reports on Senators’ reaction to Bush’s Consumer Products Safety Council nominee, who has a record of opposing safety regulation in his role as a lobbyist for the National Association of Manufacturers.
Leave additional reading suggestions in the comments.